Composition
Controlled Release Tablets of Sodium Valproate & Valproic Acid
Description
ARV-PORATE-200 CR (Controlled Release Tablets of Sodium Valproate & Valproic Acid) is an antiepileptic medicine used for the management of epilepsy, seizure disorders, and bipolar disorder, as well as for the prevention of migraine headaches. Its controlled-release formulation helps maintain consistent drug levels, providing prolonged therapeutic action and improved seizure control. Manufactured under stringent quality standards, Arvantis Pharmaceuticals ensures safe, effective, and reliable tablets with consistent therapeutic performance. These tablets are ideal for PCD Pharma Franchise, third-party manufacturing, hospital supply, institutional procurement, and bulk distribution across Delhi and India.
Enter your details to start WhatsApp chat